Cytosorbents Corporation

NASDAQ: CTSO · Real-Time Price · USD
1.15
0.01 (0.88%)
At close: Aug 15, 2025, 3:59 PM
1.14
-0.42%
After-hours: Aug 15, 2025, 06:51 PM EDT

Cytosorbents Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
1.95M -1.48M -7.88M -2.33M -4.14M -6.09M -5.83M -9.19M -6.15M -7.33M -766.13K -12.2M -10.88M -8.97M -9.31M -6.41M -4.68M -4.17M
Depreciation & Amortization
440.25K 404.75K 425.63K 428.77K 446.51K 443.21K 792.67K 462.65K 457.4K 314.07K 278.65K 277.6K 293.29K 282.09K 612.44K 237.1K 123.75K 156.32K
Stock-Based Compensation
n/a 818.43K 1.51M 486.51K 837.58K 959.47K 1.05M 1.35M 214.54K 1.08M 1.1M 1.38M 376.2K 946.48K 1.1M 1.36M 2.63M 1.11M
Other Working Capital
1.64M 257.93K -1.86M -69.64K -310.95K 886.26K -266.39K -279.27K 854K 1.43M 3,249B 215.45K 1.05M 363.2K 1.16M 228.89K 1.43M 120.99K
Other Non-Cash Items
-5.15M -2.82M 5.12M -2.32M 830.16K 248.22K -194.81K 10.71K 10.71K -526.86K -4.2M 3.22M 1.2M 1.53M 486.84K 996.5K -231.16K 442.27K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -2.3M 1.99M -231.9K n/a n/a n/a n/a n/a n/a n/a n/a 882.95K
Change in Working Capital
1.26M -388.04K -1.52M 1.28M -2.77M -391.94K 74.3K 167.74K -1.23M 3.35M -1.75M 591.33K -496.61K -1.91M 1.61M -319.09K 116.74K -767.43K
Operating Cash Flow
-1.51M -3.46M -2.34M -2.46M -4.79M -4.83M -6.41M -5.21M -6.93M -3.11M -5.34M -6.73M -8.04M -8.12M -5.49M -4.13M -2.04M -2.34M
Capital Expenditures
-36.88K -47.24K -124.19K -298.35K -119.86K -127.02K -135.92K -257.71K 209.45K -682.88K -206.08K -716.53K -4.69M -847.96K -1.67M -1.02M -984.68K -606.34K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a -45.12K -55.01K -146.62K -101.64K n/a n/a n/a -69.16K -173.22K 7.36K -76.77K -161.08K -137.72K -140.32K -125.93K -196.06K -177.7K
Investing Cash Flow
-131.76K -47.24K -124.19K -298.35K -119.86K -127.02K -135.92K -257.71K 140.28K -682.88K -206.08K -716.53K -4.69M -847.96K -1.67M -1.02M -984.68K -606.34K
Debt Repayment
n/a n/a -9.36M -57.58K 9.98M -625K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -40.36K n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 1.44M 9.36M n/a -150K n/a 4.97K 15.93K 154.83K 42.55K 5M n/a n/a -40.36K -80.92K 589.72K 129.85K 76.55K
Financial Cash Flow
-1.13K 6.83M 166.86K -99.03K 9.83M -571.76K 12.21M 648.32K 931.12K 684.28K 5M n/a n/a -40.36K -80.92K 589.72K 129.85K 76.55K
Net Cash Flow
-1.38M 3.35M -2.41M -2.77M 4.85M -5.52M 5.57M -4.79M -5.9M -3.1M -407.67K -7.61M -12.86M -9.11M -7.22M -4.57M -2.86M -2.95M
Free Cash Flow
-1.55M -3.51M -2.47M -2.76M -4.91M -4.96M -6.54M -5.46M -6.72M -3.79M -5.55M -7.45M -12.72M -8.97M -7.16M -5.15M -3.02M -2.95M